IL3 and chronic myelogenous leukemia, BCR-ABL1 positive: For example, to improve therapy of chronic myeloid leukemia (CML), researchers modified the surface of exosomes by fusing interleukin-3 (IL-3) to the N-terminal of LAMP-2B.